Literature DB >> 7613757

Bacterial translocation from the gastrointestinal tract.

R D Berg1.   

Abstract

Bacterial translocation is defined as the passage of viable indigenous bacteria from the gastrointestinal tract to extraintestinal sites, such as the mesenteric-lymph-node complex, liver, spleen and bloodstream. Three major mechanisms promote bacterial translocation: intestinal bacterial overgrowth, deficiencies in host immune defenses and increased permeability or damage to the intestinal mucosal barrier.

Entities:  

Mesh:

Year:  1995        PMID: 7613757     DOI: 10.1016/s0966-842x(00)88906-4

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  109 in total

1.  Pathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularis.

Authors:  Nicolas T Schwarz; Donna Beer-Stolz; Richard L Simmons; Anthony J Bauer
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

Review 2.  The origin of human milk bacteria: is there a bacterial entero-mammary pathway during late pregnancy and lactation?

Authors:  Juan M Rodríguez
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

3.  Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress.

Authors:  M Zareie; K Johnson-Henry; J Jury; P-C Yang; B-Y Ngan; D M McKay; J D Soderholm; M H Perdue; P M Sherman
Journal:  Gut       Date:  2006-04-25       Impact factor: 23.059

Review 4.  Gut in diseases: physiological elements and their clinical significance.

Authors:  Lian-An Ding; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

5.  Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus.

Authors:  Tiago Rafael Veloso; Frank Oechslin; Yok-Ai Que; Philippe Moreillon; José Manuel Entenza; Stefano Mancini
Journal:  Pathog Dis       Date:  2015-08-26       Impact factor: 3.166

Review 6.  Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

Review 7.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

8.  Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD.

Authors:  Roy T M Sprooten; Kaatje Lenaerts; Dionne C W Braeken; Ilvy Grimbergen; Erica P Rutten; Emiel F M Wouters; Gernot G U Rohde
Journal:  Respiration       Date:  2018-01-25       Impact factor: 3.580

Review 9.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 10.  Immune surveillance by the liver.

Authors:  Craig N Jenne; Paul Kubes
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.